Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Vascular dementia is a decline in memory, judgment, and planning caused by reduced blood flow to the brain, often from strokes, small vessel disease, or blocked and narrowed arteries. Unlike Alzheimer's, which tends to worsen gradually, it frequently progresses in a stepwise pattern: abilities drop suddenly after a new vascular event, then plateau for months or years until the next injury occurs. Symptoms depend heavily on which brain regions lose circulation, so slowed thinking, trouble concentrating, mood changes, and walking or balance problems may appear before memory loss does. Risk factors such as high blood pressure, diabetes, high cholesterol, atrial fibrillation, and smoking can be managed, which may slow or delay further steps down. There are several important distinctions and warning signs to consider, including symptoms that require emergency care, so see below for the complete answer.
If you or someone you love is noticing confusion, memory lapses, slowed thinking, or new difficulty walking, guessing at the cause can cost valuable time, because stroke related decline is often treatable and sometimes preventable when caught early. A few minutes of structured questions can help you organize what you are experiencing, learn which conditions may explain it, and understand whether you should see a primary care doctor, a neurologist, or seek urgent evaluation. Take a free, instant, online symptom check to get clearer answers and a practical plan for your next step.
Last reviewed for medical accuracy: 09/29/2026
Vascular dementia is the second most common type of dementia after Alzheimer’s disease. It occurs when blood flow to parts of the brain is reduced or blocked, leading to damage and loss of brain cells. Understanding what vascular dementia is and why it often progresses in a “stepwise” fashion can help patients, caregivers, and families prepare, recognize changes early, and seek appropriate care.
Vascular dementia arises from problems in the brain’s blood vessels. When arteries become narrowed, blocked, or ruptured, brain tissue can be starved of oxygen and nutrients. Over time, this leads to cell death and the classic cognitive changes associated with dementia.
Key points:
Several vascular conditions increase the likelihood of developing vascular dementia. Many of these overlap with risk factors for stroke and heart disease.
Major risk factors include:
By managing these risk factors through lifestyle changes, medications, and regular check-ups, it may be possible to slow or prevent progression.
Unlike Alzheimer’s disease, which tends to worsen gradually, vascular dementia often worsens in noticeable “steps.” A person may remain stable for a period, then suddenly experience a decline in cognition or function after another mini-stroke or vascular insult.
Typical symptoms may include:
The stepwise progression often follows this pattern:
Not every person experiences textbook-perfect steps, but the overall pattern of plateaus and sudden drops is a hallmark of vascular dementia.
Diagnosing vascular dementia involves several steps to confirm both the cognitive impairment and the vascular causes behind it.
Medical and neurological history
Cognitive testing
Brain imaging
Laboratory tests
Ruling out other causes
If you notice persistent memory or thinking changes in yourself or a loved one, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you understand which next steps may be appropriate.
While there is currently no cure for vascular dementia, targeted treatment and lifestyle adjustments can help slow its progression and improve quality of life.
Medical interventions:
Lifestyle modifications:
Supportive therapies:
The stepwise progression of vascular dementia reflects the underlying vascular events. Each time a blood vessel in the brain is blocked or bursts:
This differs from the slow, continuous decline seen in Alzheimer’s disease and underscores the importance of aggressive prevention of further vascular insults.
Adjusting to life with vascular dementia involves planning, support, and regular medical follow-up.
Practical tips:
Caregiver support:
Certain symptoms may signal a new stroke or other life-threatening event. If you notice sudden:
Call emergency services or go to the nearest hospital. Early treatment can reduce the extent of brain damage.
If you have concerns about memory loss or thinking difficulties, speak to a doctor. For a guided review of your symptoms, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. Always discuss any serious or life-threatening symptoms with a healthcare professional without delay.
(References)
* Mielke R, Kittner B, Ghaemi M, Kessler J, Szelies B, Herholz K, Heiss WD. Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia. J Neurol Sci. 1996 Sep 15;141(1-2):59-64. doi: 10.1016/0022-510x(96)00127-x. PMID: 8880694.
* Weyer G, Eul A, Milde K, Wierich W, Herrmann WM. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study. Pharmacopsychiatry. 2000 May;33(3):89-97. doi: 10.1055/s-2000-7978. PMID: 10855459.
* De Stefano N, Balestri P, Dotti MT, Grosso S, Mortilla M, Morgese G, Federico A. Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study. J Neurol. 2001 May;248(5):403-9. doi: 10.1007/s004150170182. PMID: 11437163.
* Mesulam M, Siddique T, Cohen B. Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology. 2003 Apr 8;60(7):1183-5. doi: 10.1212/01.wnl.0000055927.22611.eb. PMID: 12682331.
* Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord. 2003 Aug;9(6):367-9. doi: 10.1016/s1353-8020(02)00146-3. PMID: 12853237.
* Grosso S, Cerase A, De Stefano N, Marco LD, Galluzzi P, Galimberti D, Morgese G, Balestri P. Non-progressive leukoencephalopathy with bilateral anterior temporal cysts: a case report and review of the literature. Brain Dev. 2005 Jan;27(1):73-7. doi: 10.1016/j.braindev.2004.04.009. PMID: 15626547.
* Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Neurol Sci. 2006 Apr;27(1):33-9. doi: 10.1007/s10072-006-0562-6. PMID: 16688597.
* van de Pol LA, Korf ES, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol. 2007 Jul;64(7):1023-8. doi: 10.1001/archneur.64.7.1023. PMID: 17620494.
* Armstrong MJ, Hacein-Bey L, Brown H. Cerebroretinal microangiopathy with calcifications and cysts: demonstration of radiological progression. J Comput Assist Tomogr. 2009 Jul-Aug;33(4):571-2. doi: 10.1097/RCT.0b013e31818c0957. PMID: 19638852.
* Viswanathan A, Greenberg SM, Scheltens P. Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment. Stroke. 2016 Feb;47(2):577-80. doi: 10.1161/STROKEAHA.115.009010. Epub 2015 Nov 24. PMID: 26604252; PMCID: PMC4729591.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.